Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: A case report and literature review

Revista Iberoamericana de Micologia

Volumn 30, Issue 1, 2013, Pages 51-53

  Fanci, Rosa ^a   Pini, Gabriella ^a   Bartolesi, Anna Maria ^b   Pecile, Patrizia ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute leukaemia; Antifungal susceptibility; Breakthrough fusariosis; Fusarium; Immunocompromised patients

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; CLOFARABINE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FUNGAL DNA; ITRACONAZOLE; LEVOFLOXACIN; MITOXANTRONE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTIC METHOD; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANCER PATIENT; CASE REPORT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG DOSE INCREASE; EARLY DIAGNOSIS; FEMALE; FUNGAL STRUCTURES; FUNGUS IDENTIFICATION; FUSARIOSIS; FUSARIUM MONILIFORME; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LEUKEMIA RELAPSE; LOADING DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; NEUTROPENIA; NONHUMAN; SYSTEMIC MYCOSIS;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYTARABINE; DRUG RESISTANCE, MULTIPLE, FUNGAL; ETOPOSIDE; FATAL OUTCOME; FEMALE; FUSARIOSIS; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; LEUKEMIA, MYELOID, ACUTE; MITOXANTRONE; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PYRIMIDINES; RECURRENCE; SALVAGE THERAPY; TRANSPLANTATION, HOMOLOGOUS; TRIAZOLES;

FUSARIUM; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; GIBBERELLA MONILIFORMIS;

EID: 84872796975     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2012.05.003     Document Type: Article

References (29)

1. Alastruey-Izquierdo A., Cuenca-Estrella M., Monzon A., Mellado E., Rodriguez-Tudela J.L. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008, 61:805-809.
2. Bernal-Martínez L., Buitrago M.J., Castelli M.V., Rodríguez-Tudela J.L., Cuenca-Estrella M. Detection of invasive infection caused by Fusarium solani and non-Fusarium solani species using a duplex quantitative PCR-based assay in a murine model of fusariosis. Med Mycol 2011, [September 12, early online].
3. Bose P., Parekn H.D., Holter J.L., Geenfield R.A. Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis. J Clin Microbiol 2011, 49:1674-1675.
4. Bougeois G.P., Cafardi J.A., Sellheyer K., Andrea A.A. Disseminated Fusarium originating from toenail paronychia in a neutropenic patient. Cutis 2010, 4:191-194.
5. Cheson B.D., Bennett J.M., Kopecky K.J., Büchner T., Willman C.L., Estey E.H., et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003, 21:4642-4649.
6. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard, 2nd ed., vol. 28, no. 16 2008, CLSI, Wayne.
7. Consigny S., Dhedin N., Datry A., Choquet S., Leblond V., Chosidow O. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 2003, 2:311-313.
8. Cudillo L., Girmenia C., Santilli S., Picardi A., Dentamaro T., Tendas A., et al. Breakthrough fusariosis in a patient with acute lymphoblastic leukaemia receiving voriconazole prophylaxis. Clin Infect Dis 2005, 40:1212-1213.
9. Dignani M.C., Anaisse E. Human fusariosis. Clin Microbiol Infect 2004, 10:67-75.
10. Freidank H. Hyalohyphomycoses due to Fusarium spp.-two case reports and review of the literature. Mycoses 1995, 38:69-74.
11. Guarro J., Gené J. Fusarium infections, criteria for the identification of the responsible species. Mycoses 1992, 35:109-114.
12. Gupta A.K., Baran R., Summerbell R.C. Fusarium infections of the skin. Curr Opin Infect Dis 2000, 13:121-128.
13. Ho D.Y., Lee J.D., Rosso F., Montoya J.G. Treating disseminated fusariosis: amphotericin B, voriconazole or both?. Mycoses 2007, 50:227-231.
14. Hue F.X., Huerre M., Rouffault M.A., de Bievre C. Specific detection of Fusarium species in blood and tissues by a PCR technique. J Clin Microbiol 1999, 37:2434-2438.
15. Langner S., Staber P.B., Neumeister P. Posaconazole in the management of refractory invasive fungal infections. Microbiol Rev 2008, 20:695-704.
16. Liu J.Y., Chen W.T., Ko B.S., Yao M., Hsueh P.R., Hsiao C.H., et al. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: a case report and literature review. Med Mycol 2011, 49:872-878.
17. Migheli Q., Balmas V., Harak H., Sanna S., Schem B., Aoki T., et al. Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy. J Clin Microbiol 2010, 48:1076-1084.
18. Mulé G., Susca A., Stea G., Moretti A. A species-specific PCR assay based on the calmodulin partial gene for identification of Fusarium verticillioides, F. proliferatum and F. subglutinans. Eur J Plant Pathol 2004, 110:495-502.
19. Nelson P.E., Dignani M.C., Anaissie E.J. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994, 7:479-504.
20. Nucci M., Anaissie E.J., Queiroz-Telles F., Martins C.A., Trabasso P., Solza C., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003, 98:315-319.
21. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20:695-704.
22. Diagnostic molecular microbiology-principles and applications 1993, 423-430. American Society for Microbiology, Washington, DC. D.H. Persing, T.F. Smith, F.C. Tenover, T.J. White (Eds.).
23. Raad I.I., Hachem R.Y., Herbrecht R., Graybill J.R., Hare R., Concoran G., et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006, 42:1398-1403.
24. Rothe A., Seibold M., Hoppe T., Seifert H., Engert A., Caspar C., et al. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol 2004, 83:394-397.
25. Sagnelli C., Fumagalli L., Prigitano A., Baccari P., Magnani P., Lazzarin A. Successful voriconazole therapy of disseminated Fusarium verticilloides infection in an immunocompromised patient receiving chemotherapy. J Antimicrob Chemother 2006, 57:796-798.
26. Stanzani M., Vianelli G., Bandini S., Paolini M., Arpinati F., Bonifazi B., et al. Successful treatment of disseminated fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006, 53:e243-e246.
27. Tezcan G., Ozhak-Baysan B., Alastruey-Izquierdo A., Ogunc D., Ongut G., Yildiran S.T., et al. Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 2009, 47:278-281.
28. Tortorano A.M., Prigitaro A., Dho G., Esposto M.C., Grancini A., Ossi C., et al. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother 2008, 52:2683-2685.
29. Vagace J.M., Sanz-Rodriquez C., Casado M.S., Alonso N., Garcia-Dominquez M., de la Liana F.G., et al. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis 2007, 7:40.